Skip to main content
The BMJ logoLink to The BMJ
letter
. 1993 Sep 25;307(6907):798–800. doi: 10.1136/bmj.307.6907.798-c

Deciding who needs thrombolysis. Validation of ECG diagnosis inadequate.

O M Jolobe
PMCID: PMC1696439  PMID: 8219960

Full text

PDF
798

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams J., Trent R., Rawles J. Earliest electrocardiographic evidence of myocardial infarction: implications for thrombolytic treatment. The GREAT Group. BMJ. 1993 Aug 14;307(6901):409–413. doi: 10.1136/bmj.307.6901.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Marin M. M., Teichman S. L. Use of rapid serial sampling of creatine kinase MB for very early detection of myocardial infarction in patients with acute chest pain. Am Heart J. 1992 Feb;123(2):354–361. doi: 10.1016/0002-8703(92)90646-d. [DOI] [PubMed] [Google Scholar]
  3. Vermeer F., Simoons M. L., Bär F. W., Tijssen J. G., van Domburg R. T., Serruys P. W., Verheugt F. W., Res J. C., de Zwaan C., van der Laarse A. Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? Circulation. 1986 Dec;74(6):1379–1389. doi: 10.1161/01.cir.74.6.1379. [DOI] [PubMed] [Google Scholar]
  4. Yusuf S., Collins R., Lin L., Sterry H., Pearson M., Sleight P. Significance of elevated MB isoenzyme with normal creatine kinase in acute myocardial infarction. Am J Cardiol. 1987 Feb 1;59(4):245–250. doi: 10.1016/0002-9149(87)90793-4. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES